Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine in Advanced Urothelial Carcinoma
NCT07034053Phase 2Recruiting
- Start
- Oct 2023
- Primary completion
- Nov 2028
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in urothelial carcinoma (UC). Started Oct 2023; status: recruiting.
02
Drugs
clofarabine
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT07034053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07034053.